Company intelligence / Profile preview
Substipharm
Paris, Ile de France, Francesubstipharm.com ↗
- Ownership
- Private
- Employees
- ~88
- Development stage
- Commercial
01
Overview
Substipharm is a fast-growing French pharmaceutical group focused on developing and commercializing high-quality affordable medicines and vaccines. It operates globally in over 80 countries with a portfolio of more than 90 marketed molecules and an active R&D pipeline exceeding 50 projects. The company has expanded into biologics/vaccines through the acquisition of IMOJEV® for Japanese Encephalitis prevention in Asia-Pacific.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small molecules (generics, branded specialties)Vaccines/biologics
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Medigen Vaccine Biologics Corp. ("MVC") – distribution agreement for ENVACGEN® Enterovirus A71 vaccine in Southeast AsiaDompé Pharmaceuticals – acquisition of six brandsSanofi – acquisition of IMOJEV® vaccine rights
Beyond the preview
Go deeper on Substipharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Substipharm.